So targeting autophagy by knocking down AMPK/ULK1 or by combinational treatment with CQ markedly enhanced the effect of NVP-BEZ235 on tumor growth suppression both in vitro and in vivo, which may provide a critical insight into colon cancer therapy. Here, ULK1 is linked to neoplasm.